Thursday, 12 November 2026European Markets

Pound Falls to €1.13 Multi-Year Low as UK Budget Uncertainty Hits European Currency Markets

The British pound dropped 0.4% to €1.13, its lowest level since April 2023, while sliding 0.5% against the dollar to $1.3086. Mizuho Bank analysts predict GBP could break below $1.30 as fiscal uncertainty surrounding the UK's November 26 budget weighs on sentiment, creating ripple effects across European currency markets.

Pound Falls to €1.13 Multi-Year Low as UK Budget Uncertainty Hits European Currency Markets
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The British pound hit €1.13 on Tuesday, down 0.4% and marking its weakest position against the euro since April 2023. Against the dollar, sterling fell 0.5% to $1.3086 as markets braced for Chancellor Rachel Reeves' budget announcement on November 26.

Jordan Rochester at Mizuho Bank forecasts GBP could breach the $1.30 threshold. "Fiscal uncertainty is mounting," said Simon Phillips, managing director at No1 Currency. UK 30-year gilt yields climbed 4 basis points to 5.21%, the highest since August's 1998-level peak.

The pound's weakness stems from expectations of additional tax increases to address what Reeves calls a "black hole in public finances." UK inflation-linked bond auctions drew record demand—£69 billion in bids for £4.25 billion of debt, surpassing March's £67.5 billion record. Some 25% of UK gilts are tied to inflation, compared to roughly 10% in the US and France.

Neil Wilson, analyst at Saxo Markets, warned of "fiscal instability risk" affecting cross-border trade flows. European exporters face margin pressure as the stronger euro reduces competitiveness in UK markets. The euro zone's trade surplus with Britain, which reached €125 billion in 2025, could narrow if sterling continues weakening.

The Bloomberg Dollar Spot Index rose 0.1% after hitting 2022 lows, partially recovering on expectations around a new Federal Reserve chair appointment. This dollar stabilization provided limited relief to European currencies broadly.

UK political turmoil compounds currency volatility. Prime Minister Keir Starmer faces alleged leadership challenges, with Health Secretary Wes Streeting denying coup plotting while criticizing "toxic" Downing Street culture. Home Secretary Shabana Mahmood has also faced leadership speculation.

European equity markets showed resilience despite currency swings. The Stoxx 600 gained 0.6% to a record 583.4 points. France's CAC 40 rose 0.7% and Germany's DAX climbed 0.9%, suggesting investors are separating UK fiscal concerns from broader European growth prospects.

Kathleen Brooks, research director at XTB, noted gilt yield movements indicate markets are pricing in sustained UK borrowing costs. Mike Riddell at Fidelity Strategic Bond Fund called gilts the "top performer globally over recent months," though Julian Jessop at the Institute of Economic Affairs sees "no sign bond markets are rattled."

Currency traders are monitoring whether the pound's decline accelerates if the November 26 budget reveals larger-than-expected tax increases or spending cuts.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com
Pound Falls to €1.13 Multi-Year Low as UK Budget Uncertainty Hits European Currency Markets | ViaNews EU